Dwilow R, Fanella S. Invasive meningococcal disease in the 21st century—an update for the clinician. Curr Neurol Neurosci Rep. 2015;15(3):2.
Article
PubMed
Google Scholar
Hedari CP, Khinkarly RW, Dbaibo GS. Meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine: a new conjugate vaccine against invasive meningococcal disease. Infect Drug Resist. 2014;7:85–99.
CAS
PubMed
PubMed Central
Google Scholar
Jafri RZ, Ali A, Messonnier NE, Tevi-Benissan C, Durrheim D, Eskola J, Fermon F, Klugman KP, Ramsay M, Sow S, et al. Global epidemiology of invasive meningococcal disease. Popul Health Metr. 2013;11(1):17.
Article
PubMed
PubMed Central
Google Scholar
Strelow VL, Vidal JE. Invasive meningococcal disease. Arq Neuropsiquiatr. 2013;71(9B):653–8.
Article
PubMed
Google Scholar
Raja NS, Parasakthi N, Puthucheary SD, Kamarulzaman A. Invasive meningococcal disease in the University of Malaya Medical Centre, Kuala Lumpur. Malaysia J Postgrad Med. 2006;52(1):23–9 discussion 29.
CAS
PubMed
Google Scholar
Fransen F, Heckenberg SGB, Hamstra HJ, Feller M, Boog CJP, van Putten JPM, van de Beek D, van der Ende A, van der Ley P. Naturally occurring lipid a mutants in Neisseria meningitidis from patients with invasive meningococcal disease are associated with reduced coagulopathy. PLoS Pathog. 2009;5(4):e1000396.
Article
PubMed
PubMed Central
Google Scholar
Kinlin LM, Spain CV, Ng V, Johnson CC, White ANJ, Fisman DN. Environmental exposures and invasive meningococcal disease: an evaluation of effects on varying time scales. Am J Epidemiol. 2009;169(5):588–95.
Article
PubMed
PubMed Central
Google Scholar
Sadarangani M, Scheifele DW, Halperin SA, Vaudry W, Le Saux N, Tsang R, Bettinger JA, investigators of the Canadian Immunization Monitoring Program A. Outcomes of invasive meningococcal disease in adults and children in Canada between 2002 and 2011: a prospective cohort study. Clin Infect Dis. 2015;60(8):e27-35.
Article
PubMed
Google Scholar
Anonychuk A, Woo G, Vyse A, Demarteau N, Tricco AC. The cost and public health burden of invasive meningococcal disease outbreaks: a systematic review. Pharmacoeconomics. 2013;31(7):563–76.
Article
PubMed
PubMed Central
Google Scholar
WangHaji Ali AfzaliMarshall BHH. The inpatient costs and hospital service use associated with invasive meningococcal disease in South Australian children. Vaccine. 2014;32(37):4791–8.
Article
Google Scholar
Wang B, Santoreneos R, Afzali H, Giles L, Marshall H. Costs of invasive meningococcal disease: a global systematic review. Pharmacoeconomics. 2018;36(10):1201–22.
Article
PubMed
Google Scholar
Rampakakis E, Vaillancourt J, Mursleen S, Sampalis JS. Healthcare resource utilization and cost of invasive meningococcal disease in Ontario Canada. Pediatr Infect Dis J. 2019;38(3):253–7.
Article
PubMed
Google Scholar
Scholz S, Koerber F, Meszaros K, Fassbender RM, Ultsch B, Welte RR, Greiner W. The cost-of-illness for invasive meningococcal disease caused by serogroup B Neisseria meningitidis (MenB) in Germany. Vaccine. 2019;37(12):1692–701.
Article
PubMed
Google Scholar
Wang B, Haji Ali Afzali H, Giles L, Marshall H. Lifetime costs of invasive meningococcal disease: a markov model approach. Vaccine. 2019;37(46):6885–93.
Article
PubMed
Google Scholar
Huang L, Heuer OD, Janßen S, Häckl D, Schmedt N. Clinical and economic burden of invasive meningococcal disease: evidence from a large German claims database. PLoS One. 2020;15(1):e0228020.
Article
CAS
PubMed
PubMed Central
Google Scholar
Strifler L, Morris SK, Dang V, Tu HAT, Minhas RS, Jamieson FB, Deeks SL, Crowcroft NS, Sander B. The health burden of invasive meningococcal disease: a systematic review. J Pediatric Infect Dis Soc. 2016;5(4):417–30.
Article
PubMed
Google Scholar
Olbrich KJ, Müller D, Schumacher S, Beck E, Meszaros K, Koerber F. Systematic review of invasive meningococcal disease: sequelae and quality of life impact on patients and their caregivers. Infect Dis Ther. 2018;7(4):421–38.
Article
PubMed
PubMed Central
Google Scholar
Bröker M, Cooper B, Detora LM, Stoddard JJ. Critical appraisal of a quadrivalent CRM(197) conjugate vaccine against meningococcal serogroups A, C W-135 and Y (Menveo) in the context of treatment and prevention of invasive disease. Infect Drug Resist. 2011;4:137–47.
Article
PubMed
PubMed Central
Google Scholar
Bronska E, Kalmusova J, Dzupova O, Maresova V, Kriz P, Benes J. Dynamics of PCR-based diagnosis in patients with invasive meningococcal disease. Clin Microbiol Infect. 2006;12(2):137–41.
Article
CAS
PubMed
Google Scholar
Garlicki A, Bociqga-Jasik M, Kalinowska-Nowak A. Invasive meningococcal disease–management and treatment. Przegl Epidemiol. 2008;62(Suppl 1):39–44.
PubMed
Google Scholar
Nagel FW, Ezeoke I, Antwi M, Del Rosso PE, Dorsinville M, Isaac BM, Hayden A, Hoffman RS, Weingart SD, Weiss D. Delayed recognition of fatal invasive meningococcal disease in adults. JMM Case Rep. 2016;3(3):e005027.
Article
PubMed
PubMed Central
Google Scholar
Waterfield T, Fairley D, Lynn F, Blackwood B, Shields MD. A protocol for a systematic review of the diagnostic accuracy of loop-mediated-isothermal amplification (LAMP) in diagnosis of invasive meningococcal disease in children. Syst Rev. 2018;7(1):86.
Article
PubMed
PubMed Central
Google Scholar
Stinson C, Burman C, Presa J, Abalos M. Atypical presentation of invasive meningococcal disease caused by serogroup W meningococci. Epidemiol Infect. 2020;148:e12.
Article
CAS
PubMed
PubMed Central
Google Scholar
Guiddir T, Gros M, Hong E, Terrade A, Denizon M, Deghmane AE, Taha MK. Unusual initial abdominal presentations of invasive meningococcal disease. Clin Infect Dis. 2018;67(8):1220–7.
Article
PubMed
Google Scholar
Vienne P, Ducos-Galand M, Guiyoule A, Pires R, Giorgini D, Taha MK, Alonso JM. The role of particular strains of Neisseria meningitidis in meningococcal arthritis, pericarditis, and pneumonia. Clin Infect Dis. 2003;37(12):1639–42.
Article
PubMed
Google Scholar
Pelton SI, Gilmet GP. Expanding prevention of invasive meningococcal disease. Expert Rev Vaccines. 2009;8(6):717–27.
Article
CAS
PubMed
Google Scholar
Perea-Milla E, Olalla J, Sánchez-Cantalejo E, Martos F, Matute-Cruz P, Carmona-López G, Fornieles Y, Cayuela A, García-Alegría J. ANCA Group: pre-hospital antibiotic treatment and mortality caused by invasive meningococcal disease, adjusting for indication bias. BMC Public Health. 2009;9:95.
Article
PubMed
PubMed Central
Google Scholar
Papaevangelou V, Spyridis N. MenACWY-TT vaccine for active immunization against invasive meningococcal disease. Expert Rev Vaccines. 2012;11(5):523–37.
Article
CAS
PubMed
Google Scholar
Nadel S, Ninis N. Invasive meningococcal disease in the vaccine era. Front Pediatr. 2018;6:321.
Article
PubMed
PubMed Central
Google Scholar
Halperin SA, Bettinger JA, Greenwood B, Harrison LH, Jelfs J, Ladhani SN, McIntyre P, Ramsay ME, Safadi MA. The changing and dynamic epidemiology of meningococcal disease. Vaccine. 2012;30(Suppl 2):B26-36.
Article
PubMed
Google Scholar
Purmohamad A, Abasi E, Azimi T, Hosseini S, Safari H, Nasiri MJ, ImaniFooladi AA. Global estimate of Neisseria meningitidis serogroups proportion in invasive meningococcal disease: a systematic review and meta-analysis. Microb Pathog. 2019;134:103571.
Article
PubMed
Google Scholar
Neri A, Pezzotti P, Fazio C, Vacca P, D’Ancona FP, Caporali MG, Stefanelli P. Epidemiological and molecular characterization of invasive meningococcal disease in Italy, 2008/09–2012/13. PLoS One. 2015;10(10):e0139376.
Article
PubMed
PubMed Central
Google Scholar
Siu T, Tang W, Dawar M, Patrick DM. Impact of routine immunization using meningococcal C conjugate vaccine on invasive meningococcal disease in British Columbia. Can J Public Health. 2008;99(5):380–2.
Article
PubMed
PubMed Central
Google Scholar
Hellenbrand W, Elias J, Wichmann O, Dehnert M, Frosch M, Vogel U. Epidemiology of invasive meningococcal disease in Germany, 2002–2010, and impact of vaccination with meningococcal C conjugate vaccine. J Infect. 2013;66(1):48–56.
Article
PubMed
Google Scholar
Gunaratnam P, Massey P, Durrheim D, Torvaldsen S. Invasive meningococcal disease in elderly people, New South Wales, Australia, 1993 to 2012. Western Pac Surveill Response J. 2013;4(4):4–10.
PubMed
PubMed Central
Google Scholar
Whittaker R, Dias JG, Ramliden M, Ködmön C, Economopoulou A, Beer N, Pastore Celentano L. ECDC network members for invasive meningococcal disease: the epidemiology of invasive meningococcal disease in EU/EEA countries, 2004–2014. Vaccine. 2017;35(16):2034–41.
Article
PubMed
Google Scholar
Igidbashian S, Bertizzolo L, Tognetto A, Azzari C, Bonanni P, Castiglia P, Conversano M, Esposito S, Gabutti G, Icardi G, et al. Invasive meningococcal disease in Italy: from analysis of national data to an evidence-based vaccination strategy. J Prev Med Hyg. 2020;61(2):E152–61.
CAS
PubMed
PubMed Central
Google Scholar
Berghold C, Berghold A, Fülöp G, Heuberger S, Strauss R, Zenz W. Invasive meningococcal disease in Austria 2002: assessment of completeness of notification by comparison of two independent data sources. Wien Klin Wochenschr. 2006;118(1–2):31–5.
Article
PubMed
Google Scholar
Vázquez JA, Taha MK, Findlow J, Gupta S, Borrow R. Global meningococcal Initiative: guidelines for diagnosis and confirmation of invasive meningococcal disease. Epidemiol Infect. 2016;144(14):3052–7.
Article
PubMed
Google Scholar
Marten O, Koerber F, Bloom D, Bullinger M, Buysse C, Christensen H, De Wals P, Dohna-Schwake C, Henneke P, Kirchner M, et al. A DELPHI study on aspects of study design to overcome knowledge gaps on the burden of disease caused by serogroup B invasive meningococcal disease. Health Qual Life Outcomes. 2019;17(1):87.
Article
PubMed
PubMed Central
Google Scholar
GBD 2016 Meningitis Collaborators. Global, regional, and national burden of meningitis, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018;17(12):1061–82.
Article
Google Scholar
Gray S, Campbell H, Walker A, Patel S, Willerton L, Lekshmi A, Clark S, Bai X, Ribeiro S, Parikh S et al. Epidemiology and surveillance of meningococcal disease in England. 2019. https://www.meningitis.org/getmedia/6c45bf47-f09a-4771-87b2-8ed57fc0b67d/Dr-Steve-Gray?disposition=attachment. Accessed 11 Nov 2020. In., vol. 2020; 2019.
Stefanelli P, Fazio C, Neri A, Di Taranto A, Labonia M, De Robertis AL, Loconsole D, Martinelli D, Chironna M. Twenty years of surveillance of invasive meningococcal diseases in Puglia Italy. Ann Ist Super Sanita. 2015;51(4):366–70.
PubMed
Google Scholar
Säll O, Stenmark B, Glimåker M, Jacobsson S, Mölling P, Olcén P, Fredlund H. Clinical presentation of invasive disease caused by Neisseria meningitidis serogroup Y in Sweden, 1995 to 2012. Epidemiol Infect. 2017;145(10):2137–43.
Article
PubMed
Google Scholar
Folaranmi TA, Kretz CB, Kamiya H, MacNeil JR, Whaley MJ, Blain A, Antwi M, Dorsinville M, Pacilli M, Smith S, et al. Increased risk for meningococcal disease among men who have sex with men in the United States, 2012–2015. Clin Infect Dis. 2017;65(5):756–63.
Article
PubMed
Google Scholar
Edge C, Waight P, Ribeiro S, Borrow R, Ramsay M, Ladhani S. Clinical diagnoses and outcomes of 4619 hospitalised cases of laboratory-confirmed invasive meningococcal disease in England: linkage analysis of multiple national databases. J Infect. 2016;73(5):427–36.
Article
PubMed
Google Scholar
Campbell H, Andrews N, Parikh S, Ribeiro S, Gray S, Lucidarme J, Ramsay ME, Borrow R, Ladhani SN. Variable clinical presentation by the main capsular groups causing invasive meningococcal disease in England. J Infect. 2020;80(2):182–9.
Article
PubMed
Google Scholar
Ortiz de Zárate J, Arana M, Asencor M, Mojica C, Trallero E. Epidemiology and characterization of invasive Neisseria meningitidis serogroup Y isolates in Basque country (Northern Spain) from 1995 to 2014. 2016. https://www.escmid.org/escmid_publications/escmid_elibrary/material/?mid=45891. Accessed 24 Mar 2021. In., vol. 2021; 2016.
Parisi S, Azzari C, Bonanni P, Castiglia P, Conversano M, Icardi G, Tognetto A, Checcucci Lisi G. Invasive meningococcal diseases in Italy: an analysis of national surveillance data, 2011–2017. 2019. https://espidmeeting.org/wp-content/uploads/sites/21/2019/05/ESPID-2019-Accepted-Abstracts-Listed.pdf. Accesssed 24 Mar 2021. In., vol. 2021; 2019.
Stoof SP, Rodenburg GD, Knol MJ, Rümke LW, Bovenkerk S, Berbers GAM, Spanjaard L, van der Ende A, Sanders EAM. Disease burden of invasive meningococcal disease in the Netherlands between June 1999 and June 2011: a subjective role for serogroup and clonal complex. Clin Infect Dis. 2015;61(8):1281–92.
Article
PubMed
Google Scholar
Loenenbach AD, van der Ende A, de Melker HE, Sanders EAM, Knol MJ. The clinical picture and severity of invasive meningococcal disease serogroup W compared with other serogroups in the Netherlands, 2015–2018. Clin Infect Dis. 2020;70(10):2036–44.
Article
PubMed
Google Scholar
Eriksson L, Hedberg ST, Jacobsson S, Fredlund H, Mölling P, Stenmark B. Whole-genome sequencing of emerging invasive Neisseria meningitidis serogroup W in Sweden. J Clin Microbiol. 2018;56(4):e01409-01417.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bennett D, O’Lorcain P, Morgan S, Cotter S, Cafferkey M, Cunney R. Epidemiology of two decades of invasive meningococcal disease in the Republic of Ireland: an analysis of national surveillance data on laboratory-confirmed cases from 1996 to 2016. Epidemiol Infect. 2019;147:e142.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bijlsma MW, Brouwer MC, Kasanmoentalib ES, Kloek AT, Lucas MJ, Tanck MW, van der Ende A, van de Beek D. Community-acquired bacterial meningitis in adults in the Netherlands, 2006–14: a prospective cohort study. Lancet Infect Dis. 2016;16(3):339–47.
Article
PubMed
Google Scholar
Clarke C, Mallonee S. State-based surveillance to determine trends in meningococcal disease. Public Health Rep. 2009;124(2):280–7.
Article
PubMed
PubMed Central
Google Scholar
Peruski AH, Kludt P, Patel RS, DeMaria A. Secular trends in invasive meningococcal disease, Massachusetts, 1988–2011: what happened to invasive disease? Epidemiol Infect. 2014;142(12):2483–90.
Article
CAS
PubMed
Google Scholar
Baccarini C, Ternouth A, Wieffer H, Vyse A. The changing epidemiology of meningococcal disease in North America 1945–2010. Hum Vaccin Immunother. 2013;9(1):162–71.
Article
PubMed
Google Scholar
Gil-Prieto R, García-García L, Alvaro-Meca A, González-Escalada A, Viguera Ester P, De GilMiguel A. The burden of hospitalizations for meningococcal infection in Spain (1997–2008). Vaccine. 2011;29(34):5765–70.
Article
PubMed
Google Scholar
Cabellos C, Verdaguer R, Olmo M, Fernández-Sabé N, Cisnal M, Ariza J, Gudiol F, Viladrich PF. Community-acquired bacterial meningitis in elderly patients: experience over 30 years. Medicine (Baltimore). 2009;88(2):115–9.
Article
Google Scholar
Goldacre MJ, Maisonneuve JJ. Mortality from meningococcal disease by day of the week: english national linked database study. J Public Health (Oxf). 2013;35(3):413–21.
Article
Google Scholar
du ParentChatelet I, Deghmane AE, Antona D, Hong E, Fonteneau L, Taha MK, Levy-Bruhl D. Characteristics and changes in invasive meningococcal disease epidemiology in France, 2006–2015. J Infect. 2017;74(6):564–74.
Article
Google Scholar
Bai X, Borrow R, Bukovski S, Caugant DA, Culic D, Delic S, Dinleyici EC, Eloshvili M, Erdősi T, Galajeva J, et al. Prevention and control of meningococcal disease: updates from the global meningococcal initiative in Eastern Europe. J Infect. 2019;79(6):528–41.
Article
PubMed
Google Scholar
Skoczyńska A, Waśko I, Kuch A, Kadłubowski M, Gołębiewska A, Foryś M, Markowska M, Ronkiewicz P, Wasiak K, Kozińska A, et al. A decade of invasive meningococcal disease surveillance in Poland. PloS One. 2013;8(8):e71943.
Article
PubMed
PubMed Central
Google Scholar
Beebeejaun K, Parikh SR, Campbell H, Gray S, Borrow R, Ramsay ME, Ladhani SN. Invasive meningococcal disease: timing and cause of death in England, 2008–2015. J Infect. 2020;80(3):286–90.
Article
PubMed
Google Scholar
Knol MJ, Hahné SJM, Lucidarme J, Campbell H, de Melker HE, Gray SJ, Borrow R, Ladhani SN, Ramsay ME, van der Ende A. Temporal associations between national outbreaks of meningococcal serogroup W and C disease in the Netherlands and England: an observational cohort study. Lancet Public Health. 2017;2(10):e473–82.
Article
PubMed
Google Scholar
Masson-Behar V, Jacquier H, Richette P, Ziza J-M, Zeller V, Rioux C, Coustet B, Dieudé P, Ottaviani S. Arthritis secondary to meningococcal disease: a case series of 7 patients. Medicine (Baltimore). 2017;96(29):e7573.
Article
Google Scholar
Cikirikcioglu M, Schrenzel J, Emonet S, Muller H, Ellenberger C, Giraud R, Kaiser L, Huber C. Keep in mind extremely rare etiologies!!! Meningococcal aortic valve endocarditis. Kardiovaskulare Medizin. 2017;20(5):S123.
Google Scholar
Bajaj D, Agrawal A, Gandhi D, Varughese R, Gupta S, Regelmann D. Intraventricular empyema caused by Neisseria meningitidis. IDCases. 2019;15:e00503.
Article
PubMed
PubMed Central
Google Scholar
Keeley AJ, Hammersley D, Dhamrait SS. A case of myopericarditis caused by Neisseria meningitidis W135 serogroup with protracted inflammatory syndrome. Clin Med (Lond). 2018;18(3):253–5.
Article
Google Scholar
Walayat S, Hussain N, Malik AH, Vazquez-Melendez E, Aulakh BS, Lynch T. Invasive meningococcal disease without meningitis: a forgotten diagnosis. Int Med Case Rep J. 2018;11:87–90.
Article
PubMed
PubMed Central
Google Scholar
Romero-Gomez MP, Rentero Z, Paño JR, Mingorance J. Bacteraemic pneumonia caused by Neisseria meningitidis serogroup Y. Respir Med Case Rep. 2012;5(1):23–4.
PubMed
Google Scholar
Singh D, Swann A. Skin demarcation and amputation level for foot gangrene following meningococcal septicemia. Foot Ankle Spec. 2013;6(5):384–8.
Article
PubMed
Google Scholar
Arnáiz-García ME, Arnáiz-García AM, Gutierrez-Diez F, Nistal JF, González-Santos JM, Pulitani I, Amado-Diago C, Arnáiz J. Mutilating purpura fulminans in an adult with meningococcal sepsis. P R Health Sci J. 2017;36(3):179–82.
PubMed
Google Scholar
Zimmermann T, Chmiel C. Neisseria meningitidis sepsis in a patient with acute epiglottitis and respiratory failure. BMJ Case Rep. 2018;2018:bcr2017223388.
Article
PubMed Central
Google Scholar
Rosenfield L, Cvetkovic A, Woodward K, Quirt J. Late presentation of possible terminal compliment deficiency with recurrent Neisseria meningitides infection. Allergy Asthma Clin Immunol. 2017;13(Suppl 1):A38.
Google Scholar
Lesourd A, Magne N, Soares A, Lemaitre C, Taha M-K, Gueit I, Wolff M, Caron F. Primary bacterial ventriculitis in adults, an emergent diagnosis challenge: report of a meningoccal case and review of the literature. BMC Infect Dis. 2018;18(1):226.
Article
PubMed
PubMed Central
Google Scholar
Lawler J, Lucidarme J, Parikh S, Smith L, Campbell H, Borrow R, Gray S, Foster K, Ladhani S. Suspected cluster of Neisseria meningitidis W invasive disease in an elderly care home: do new laboratory methods aid public health action? United Kingdom, 2015. Euro Surveill. 2019;24(23):1900070.
Article
PubMed Central
Google Scholar
Puleston R, Beck C, Tahir M, Bardhan M, Charlemagne P, Alves C, Ladhani S, Watson C, Ramsay M, Kaczmarksi E, et al. An unusual transmission event of Neisseria meningitidis serogroup W135 type 2a in a healthcare setting, England, 2012. Euro Surveill. 2012;17(44):20308.
Article
PubMed
Google Scholar
Russcher A, Fanoy E, van Olden GDJ, Graafland AD, van der Ende A, Knol MJ. Necrotising fasciitis as atypical presentation of infection with emerging Neisseria meningitidis serogroup W (MenW) clonal complex 11, the Netherlands, March 2017. Euro Surveill. 2017;22(23):30549.
Article
PubMed
PubMed Central
Google Scholar
Ladhani SN, Lucidarme J, Newbold LS, Gray SJ, Carr AD, Findlow J, Ramsay ME, Kaczmarski EB, Borrow R. Invasive meningococcal capsular group Y disease, England and Wales, 2007–2009. Emerg Infect Dis. 2012;18(1):63–70.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ristic M, Seguljev Z, Petrovic V, Rajcevic S. Epidemiological charactheristics of meningococcal disease in Vojvodina (Serbia) at the beggining of 21st Century. HealthMED. 2012;6(7):2550–4.
Google Scholar
Pellegrino P, Carnovale C, Perrone V, Salvati D, Gentili M, Brusadelli T, Antoniazzi S, Pozzi M, Radice S, Clementi E. Epidemiological analysis on two decades of hospitalisations for meningitis in the United States. Eur J Clin Microbiol Infect Dis. 2014;33(9):1519–24.
Article
CAS
PubMed
Google Scholar
Meningitis progress tracker [https://www.meningitis.org/mpt]
Disease data from ECDC surveillance atlas for meningococcal disease [https://www.ecdc.europa.eu/en/meningococcal-disease/surveillance-and-disease-data/atlas].
Polkowska A, Toropainen M, Ollgren J, Lyytikäinen O, Nuorti JP. Bacterial meningitis in Finland, 1995–2014: a population-based observational study. BMJ Open. 2017;7(5):e015080.
Article
PubMed
PubMed Central
Google Scholar
Meningococcal disease [https://www.cdc.gov/meningococcal/index.html].
Rapport d'activite 2014 [https://www.pasteur.fr/fr/file/3273/download?token=8UaruHXt].
Active Bacterial Core Surveillance Report, Emerging Infections Program Network, Neisseria meningitidis, 2018 [https://www.cdc.gov/abcs/reports-findings/survreports/mening18.html].
Bodilsen J, Brandt CT, Sharew A, Dalager-Pedersen M, Benfield T, Schønheyder HC, Nielsen H. Early versus late diagnosis in community-acquired bacterial meningitis: a retrospective cohort study. Clin Microbiol Infect. 2018;24(2):166–70.
Article
CAS
PubMed
Google Scholar
Wang B, Santoreneos R, Giles L, Haji Ali Afzali H, Marshall H. Case fatality rates of invasive meningococcal disease by serogroup and age: a systematic review and meta-analysis. Vaccine. 2019;37(21):2768–82.
Article
PubMed
Google Scholar
Reese HE, Ronveaux O, Mwenda JM, Bita A, Cohen AL, Novak RT, Fox LM, Soeters HM. Invasive meningococcal disease in Africa’s meningitis belt: more than just meningitis? J Infect Dis. 2019;220(220 Suppl 4):S263–5.
Article
PubMed
Google Scholar
Taha MK, Presa J, Serra L. A review of the epidemiology of invasive meningococcal disease and vaccination strategies in North Africa. Int J Infect Dis. 2020;104:189–97.
Article
PubMed
Google Scholar
Lahra MM, Enriquez RP, George CRR. Australian meningococcal surveillance programme annual report, 2017. Commun Dis Intell. 2018;2019:43.
Google Scholar
Fukusumi M, Kamiya H, Takahashi H, Kanai M, Hachisu Y, Saitoh T, Ohnishi M, Oishi K, Sunagawa T. National surveillance for meningococcal disease in Japan, 1999–2014. Vaccine. 2016;34(34):4068–71.
Article
PubMed
Google Scholar
Pomar V, Benito N, López-Contreras J, Coll P, Gurguí M, Domingo P. Characteristics and outcome of spontaneous bacterial meningitis in patients with cancer compared to patients without cancer. Medicine (Baltimore). 2017;96(19):e6899.
Article
CAS
Google Scholar
Domingo P, Pomar V, Benito N, Coll P. The changing pattern of bacterial meningitis in adult patients at a large tertiary university hospital in Barcelona, Spain (1982–2010). J Infect. 2013;66(2):147–54.
Article
PubMed
Google Scholar
Tuite AR, Kinlin LM, Kuster SP, Jamieson F, Kwong JC, McGeer A, Fisman DN. Respiratory virus infection and risk of invasive meningococcal disease in central Ontario, Canada. PloS One. 2010;5(11):e15493.
Article
PubMed
PubMed Central
Google Scholar
Muscat M, Spiteri G, Calleja N, Haider J, Gray SJ, Melillo JM, Mamo J, Cuschieri P. Invasive meningococcal disease in Malta: an epidemiological overview, 1994–2007. J Med Microbiol. 2009;58(Pt 11):1492–8.
Article
PubMed
Google Scholar
Passmore E, Ferson MJ, Tobin S. EpiReview: meningococcal disease in NSW, 1991–2011: trends in relation to meningococcal C vaccination. N S W Public Health Bull. 2013;24(3):119–24.
PubMed
Google Scholar
Carville KS, Stevens K, Sohail A, Franklin LJ, Bond KA, Brahmi A, Romanes F, Ong KS. Increase in meningococcal serogroup W disease, Victoria, Australia, 2013–2015. Emerg Infect Dis. 2016;22(10):1785–7.
Article
PubMed
PubMed Central
Google Scholar
Centers for Disease Control and Prevention. Prevention: Notes from the field: serogroup C invasive meningococcal disease among men who have sex with men - New York City, 2010–2012. MMWR Morb Mortal Wkly Rep. 2013;61(51–52):1048.
Google Scholar
Marcus U, Vogel U, Schubert A, Claus H, Baetzing-Feigenbaum J, Hellenbrand W, Wichmann O. A cluster of invasive meningococcal disease in young men who have sex with men in Berlin, October 2012 to May 2013. Euro Surveill. 2013;18(28):20523.
Article
PubMed
Google Scholar
Martín-Sánchez M, Fairley CK, Bradshaw CS, Chen MY, Chow EPF. Meningococcal vaccine uptake among men who have sex with men in response to an invasive meningococcal C disease outbreak in Melbourne Australia. Sex Transm Infect. 2020;96(4):246–50.
Article
PubMed
Google Scholar
Safadi MA, de Moraes J, Moraes C. A critical analysis of the epidemiologic profile of serogroup B meningococcal disease in Brazil, 2001–2015. 2021. https://espid2017.kenes.com/Documents/ESPID17%20abstracts.pdf. Accessed 25 Mar 2021. In., vol. 2021; 2017.
de TrzewikoswkiLima G, De Gaspari E. Study of the immune response in the elderly: is it necessary to develop a vaccine against Neisseria meningitidis for the aged? J Aging Res. 2019;2019:9287121.
Google Scholar
van Kessel F, van den Ende C, Oordt-Speets AM, Kyaw MH. Outbreaks of meningococcal meningitis in non-African countries over the last 50 years: a systematic review. J Glob Health. 2019;9:1 010411.
PubMed
Google Scholar
Peterson ME, Li Y, Bita A, Moureau A, Nair H, Kyaw MH, Meningococcal Surveillance Group, Abad R, Bailey F, Garcia IF, et al. Meningococcal serogroups and surveillance: a systematic review and survey. J Glob Health. 2019;9(1):010409.
Article
PubMed
Google Scholar
Cabrera-Gaytán DA, Pérez-Pérez GF, Arriaga-Nieto L, Vallejos-Parás A, Padilla-Velázquez R, Grajales-Muñiz C. Epidemiological surveillance of meningeal and encephalic syndrome in the Mexican social security Institute, 2012–2014. Rev Med Hosp Gen (Mex). 2017;80(3):130–8.
Google Scholar
Mbaeyi SA, Blain A, Whaley MJ, Wang X, Cohn AC, MacNeil JR. Epidemiology of meningococcal disease outbreaks in the United States, 2009–2013. Clin Infect Dis. 2019;68(4):580–5.
Article
PubMed
Google Scholar
Brueggemann AB, van JansenRensburg MJ, Shaw D, McCarthy ND, Jolley KA, Maiden MCJ, van der Linden MPG, Amin-Chowdhury Z, Bennett DE, Borrow R, et al. Changes in the incidence of invasive disease due to streptococcus pneumoniae, haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the invasive respiratory infection surveillance initiative: a prospective analysis of surveillance data. Lancet Digit Health. 2021;3(6):e360–70.
Article
PubMed
PubMed Central
Google Scholar
Taha MK, Deghmane AE. Impact of COVID-19 pandemic and the lockdown on invasive meningococcal disease. BMC Res Notes. 2020;13(1):399.
Article
CAS
PubMed
PubMed Central
Google Scholar
Calendario vaccinale per la vita 2019 [https://www.vaccinarsi.org/notizie/2019/07/%E2%80%8Bcalendario-vaccinale-per-la-vita-2019].